Eric Eugene Esser - Jun 15, 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
Chief Operating Officer
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 04:15 PM
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) +Grant/Award $0 +225,000 $0.00 225,000 Jun 15, 2022 Common Stock 225,000 $2.71 Direct F1

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining Shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 1, 2022.